Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Climb Bio

Market Cap: US$148.4m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

Quality Chemical Industries

Market Cap: USh430.9b

Manufactures and sells pharmaceutical drugs in Uganda.

Atea Pharmaceuticals

Market Cap: US$230.1m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Innovotech

Market Cap: CA$9.5m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Karolinska Development

Market Cap: SEK 242.8m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

MediWound

Market Cap: US$196.0m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

Talphera

Market Cap: US$42.1m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Nkarta

Market Cap: US$146.3m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Structure Therapeutics

Market Cap: US$1.5b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Poolbeg Pharma

Market Cap: UK£26.8m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

Corbus Pharmaceuticals Holdings

Market Cap: US$141.2m

A biopharmaceutical company, develops products to defeat serious illness.

ArriVent BioPharma

Market Cap: US$724.6m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Polyrizon

Market Cap: US$12.7m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

Design Therapeutics

Market Cap: US$366.7m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Clearmind Medicine

Market Cap: US$5.6m

A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

Universe Pharmaceuticals

Market Cap: US$2.3m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China.

CytomX Therapeutics

Market Cap: US$397.4m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م3.2b

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

Grace Therapeutics

Market Cap: US$42.9m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Psyence Group

Market Cap: CA$2.2m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

Puma Biotechnology

Market Cap: US$237.7m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Thor Medical

Market Cap: NOK 1.3b

Produces and supplies alpha-particle emitters for cancer therapy in Norway.

Abera Bioscience

Market Cap: SEK 105.2m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Corvus Pharmaceuticals

Market Cap: US$482.9m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Galmed Pharmaceuticals

Market Cap: US$7.9m

A biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.

ImmuCell

Market Cap: US$54.8m

An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

Pulike Biological Engineering

Market Cap: CN¥4.6b

Engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs.

Chugai Pharmaceutical

Market Cap: JP¥10.9t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Whan In PharmLtd

Market Cap: ₩163.8b

Manufactures and sells various pharmaceuticals products in South Korea.

Kidswell Bio

Market Cap: JP¥12.9b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

CellSource

Market Cap: JP¥11.4b

Engages in the regenerative medicine-related businesses in Japan.

TMS

Market Cap: JP¥7.1b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

LTR Pharma

Market Cap: AU$122.2m

A clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

CanBas

Market Cap: JP¥22.8b

A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.

Oneness Biotech

Market Cap: NT$31.8b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

Ever Supreme Bio Technology

Market Cap: NT$15.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.